The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Asymmetric Dimethylarginine Plasma Concentrations Differ in Patients with End-Stage Renal Disease: Relationship to Treatment Method and Atherosclerotic Disease
Abstract
: Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of endothelial nitric oxide (NO) synthase. Its concentration is elevated in patients with end-stage renal disease (ESRD), in part because it is excreted via the kidneys. In this study, the plasma concentrations of ADMA, symmetric dimethylarginine, and L-arginine were determined in relation to plasma nitrate levels (as an index of NO formation) for a group of 80 patients with ESRD. The effects of two treatment methods, i.e., hemodialysis (HD) and peritoneal dialysis (PD), and the role of the presence of atherosclerotic disease were evaluated. Forty-three patients receiving HD and 37 patients receiving PD were compared with healthy control subjects. Plasma L-arginine and dimethylarginine levels were determined by HPLC, using precolumn derivatization with o-phthaldialdehyde. Plasma nitrate levels were determined by gas chromatography-mass spectrometry. Predialysis ADMA concentrations in HD-treated patients were approximately sixfold higher than those in the control group (6.0 ± 0.5 versus 1.0 ± 0.1 μmol/L; P < 0.05). Plasma nitrate concentrations were significantly lower in HD-treated patients, which suggests that ADMA may inhibit NO synthase. In contrast, plasma ADMA levels and nitrate concentrations in PD-treated patients were similar to those in control subjects. Plasma L-arginine concentrations were not significantly decreased in patients with ESRD. ADMA concentrations were significantly decreased 5 h after HD, compared with baseline values. ADMA levels were significantly higher in HD-treated patients with manifest atherosclerotic disease than in HD-treated patients without atherosclerotic disease (7.31 ± 0.70 versus 3.95 ± 0.52 μmol/L; P < 0.05). This study confirms that ADMA is accumulated in ESRD. PD-treated patients exhibit significantly lower ADMA levels than do HD-treated patients. Accumulation of ADMA may be a risk factor for the development of endothelial dysfunction and cardiovascular disease in patients with ESRD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107
Accelerated Atherosclerosis in Prolonged Maintenance Hemodialysis
Lindner, A., Charra, B., Sherrard, D. J., & Scribner, B. H. (1974) · New England Journal of Medicine · doi:10.1056/nejm197403282901301 · Cited by 1,776
Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181
Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.
Förstermann, U., Closs, E. I., Pollock, J. S., Nakane, M., Schwarz, P., Gath, I., & Kleinert, H. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.1121 · Cited by 1,111
Rees, D. D., Palmer, R. M. J., Hodson, H. F., & Moncada, S. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb11833.x · Cited by 850
Baylis, C., Mitruka, B., & Deng, A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115849 · Cited by 729
Cayatte, A. J., Palacino, J. J., Horten, K., & Cohen, R. A. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.753 · Cited by 493
Böger, R. H., Bode-Böger, S. M., Thiele, W., Junker, W., Alexander, K., & Frölich, J. C. (1997) · Circulation · doi:10.1161/01.cir.95.8.2068 · Cited by 490
Endogenous Dimethylarginine as an Inhibitor of Nitric Oxide Synthesis
Vallance, P., Leone, A., Calver, A., Collier, J., & Moncada, S. (1992) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199204002-00018 · Cited by 469
Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase
MacAllister, R. J., Parry, H., Kimoto, M., Ogawa, T., Russell, R. J., Hodson, H., Whitley, G. S. J., & Vallance, P. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16069.x · Cited by 393
Atherosclerosis and arteriosclerosis in chronic renal failure
London, G. M., & Drüeke, T. B. (1997) · Kidney International · doi:10.1038/ki.1997.233 · Cited by 354
Bode-Böger, S. M., Böger, R. H., Kienke, S., Junker, W., & Frölich, J. C. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0279 · Cited by 304
Self-citationNaruse, K., Shimizu, K., Muramatsu, M., Toki, Y., Miyazaki, Y., Okumura, K., Hashimoto, H., & Ito, T. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.746 · Cited by 256
The L-Arginine: Nitric Oxide Pathway Is the Major Source of Plasma Nitrite in Fasted Humans
Rhodes, P. M., Leone, A. M., Francis, P. L., Struthers, A. D., & Moncada, S. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1541 · Cited by 254
Böger, R. H., Bode-Böger, S. M., Brandes, R. P., Phivthong-ngam, L., Böhme, M., Nafe, R., Mügge, A., & Frölich, J. C. (1997) · Circulation · doi:10.1161/01.cir.96.4.1282 · Cited by 242
Physiology and biochemistry of endothelial function in children with chronic renal failure
Kari, J. A., Donald, A. E., Vallance, D. T., Bruckdorfer, K. R., Leone, A., Mullen, M. J., Bunce, T., Dorado, B., Deanfield, J. E., & Rees, L. (1997) · Kidney International · doi:10.1038/ki.1997.354 · Cited by 220
Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure
MacAllister, R. J., Rambausek, M. H., Vallance, P., Williams, D., Hoffmann, K.-H., & Ritz, E. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.12.2449 · Cited by 204
Tojo, A., Welch, W. J., Bremer, V., Kimoto, M., Kimura, K., Omata, M., Ogawa, T., Vallance, P., & Wilcox, C. S. (1997) · Kidney International · doi:10.1038/ki.1997.490 · Cited by 200
McDermott, J. R. (1976) · Biochemical Journal · doi:10.1042/bj1540179 · Cited by 192
Anderstam, B., Katzarski, K., & Bergström, J. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v891437 · Cited by 168
MacAllister, R. J., Fickling, S. A., Whitley, G. S. J., & Vallance, P. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb13026.x · Cited by 162
Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase
Faraci, F. M., Brian, J. E., & Heistad, D. D. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.269.5.h1522 · Cited by 159
Kimoto, M., Whitley, G. S. J., Tsuji, H., & Ogawa, T. (1995) · The Journal of Biochemistry · doi:10.1093/jb/117.2.237 · Cited by 156
Metabolism of NG,NG- and NG,NG-dimethylarginine in rats
Ogawa, T., Kimoto, M., Watanabe, H., & Sasaoka, K. (1987) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(87)90060-9 · Cited by 138
Tsikas, D., Böger, R. H., Bode‐Böger, S. M., Gutzki, F. M., & Frölich, J. C. (1994) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(94)00374-2 · Cited by 129
Self-citationHand, M. F., Haynes, W. G., & Webb, D. J. (1998) · Kidney International · doi:10.1111/j.1523-1755.1998.00851.x · Cited by 121
Kimoto, M., Tsuji, H., Ogawa, T., & Sasaoka, K. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1091 · Cited by 118
Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis
Joannidès, R., Bakkali, E. H., Roy, F. L., et al. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.12.2623 · Cited by 110
Effects of an endogenous inhibitor of nitric oxide synthesis on postcapillary venules
Kurose, I., Wolf, R., Grisham, M. B., & Granger, D. N. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.268.6.h2224 · Cited by 98
Synthesis of NG, NGDimethylarginine by Human Endothelial Cells
Fickling, S. A., Leone, A. M., Nussey, S. S., Vallance, P. J., & Whitley, G. S. J. (1993) · Endothelium · doi:10.3109/10623329309102688 · Cited by 78
Low Nitric Oxide Production in Patients with Chronic Renal Failure
Blum, M., Yachnin, T., Wollman, Y., Chernihovsky, T., Peer, G., Grosskopf, I., Kaplan, E., Silverberg, D. S., Cabili, S., & Iaina, A. (1998) · The Nephron journals/Nephron journals · doi:10.1159/000045047 · Cited by 75
Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients.
Wanner, C., Zimmermann, J., Quaschning, T., & Galle, J. (1997) · PubMed · Cited by 68
Nitric oxide release in the peripheral blood during hemodialysis
Rysz, J., Luciak, M., Kędziora, J., Błaszczyk, J., & Sibińska, E. (1997) · Kidney International · doi:10.1038/ki.1997.36 · Cited by 41
Cited by
Zoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07217-8 · Cited by 1,087
Self-citationOxidative stress in end-stage renal disease: an emerging threat to patient outcome
Locatelli, F., Canaud, B., Eckardt, K.-U., Stenvinkel, P., Wanner, C., & Zoccali, C. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg074 · Cited by 758
Homocysteine Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine
Stühlinger, M. C., Tsao, P. S., Her, J.-H., Kimoto, M., Balint, R. F., & Cooke, J. P. (2001) · Circulation · doi:10.1161/hc4601.098514 · Cited by 662
Lin, K. Y., Ito, A., Asagami, T., Tsao, P. S., Adimoolam, S., Kimoto, M., Tsuji, H., Reaven, G. M., & Cooke, J. P. (2002) · Circulation · doi:10.1161/01.cir.0000027109.14149.67 · Cited by 651
Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor
Stühlinger, M. C. (2002) · JAMA · doi:10.1001/jama.287.11.1420 · Cited by 581
Metadata
- Authors
- KIELSTEIN, J. T., BÖGER, R. H., BODE-BÖGER, S. M., SCHÄFFER, J., BARBEY, M., KOCH, K. M., & FRÖLICH, J. C.
- Venue
- Journal of the American Society of Nephrology
- Published
- 1999-03
- Volume
- 10
- Issue
- 3
- Pages
- 594-600
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2151296579
- Cited by
- 361
- References
- 34
- FWCI
- 9.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.